Need professional-grade analysis? Visit stockanalysis.com
$3.23B
55.00
1,266
2.42%
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - General industry. The stock currently trades at CNY5.96, down 4.94% from the previous close.
Over the past year, 600613 has traded between a low of CNY5.72 and a high of CNY7.19. The stock has lost 4.2% over this period. It is currently 17.1% below its 52-week high.
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A has a market capitalization of $3.23B, with a price-to-earnings ratio of 55.00 and a dividend yield of 2.42%.
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidin injection, loquat cough granules, strong loquat dew, loquat cough capsules, jinwu gutong capsules, coral ringworm net, jingwu capsules, quantianma capsules, yindan xintai pills, etc. The company was founded in 1990 and is based in Shanghai, China.
Side-by-side comparison against top Healthcare peers.